Evidence map›Paper›PMID 29268712›Full record

ArticleBMC cardiovascular disorders2017

Retinal capillary rarefaction in patients with untreated mild-moderate hypertension.

Agnes J Bosch, Joanna M Harazny, Iris Kistner, Stefanie Friedrich, Joanna Wojtkiewicz, Roland E Schmieder

5 registry-linked trialsAbstract read
In one paragraph

Article in BMC cardiovascular disorders, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 5 registered trials, which are not on this map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00152698 phase3withdrawnnot on this map

A Randomised, Double-blind, Placebo-controlled, Phase III Trial to Study the Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With Hypercholesterolemia

TypeinterventionalSponsorUniversity of Erlangen-Nürnberg Medical SchoolRan2009 to 2009Enrolled0ConditionsHypercholesterolemiaArmsIrbesartan
NCT00627952 phase3completednot on this map

Double Blind, Randomized, Parallel Group, Multicentre Study to Evaluate the Effects of Manidipine 20 MG Vs. Amlodipine 10 MG and the Combination of Manidipine 10 MG Plus Delapril 30 MG Vs. Amlodipine 5 MG Plus Delapril 30 MG on Intraglomerular Pressure in Hypertensive Patients

TypeinterventionalSponsorUniversity of Erlangen-Nürnberg Medical SchoolRan2007 to 2008Enrolled100ConditionsHypertensionArmsamlodipine 10 mg, manidipine 20 mg, amlodipine 5 mg + delapril 30 mg, manidipine 10 mg + delapril 30 mg
NCT01318395 phase3completednot on this map

Randomized, Double Blind, Active-controlled, Parallel Study to Analyse Effects of the Combination of Aliskiren and Valsartan on the Vascular Structure and Function of Retinal Vessels

TypeinterventionalSponsorUniversity of Erlangen-Nürnberg Medical SchoolRan2010 to 2013Enrolled56ConditionsArterial HypertensionArmsAliskiren, Placebo
NCT01319344 phase3completednot on this map

Prospective and Open Label Study With Blind End Point Evaluation on the Effect of Mineralocorticoid Receptor Inhibition on Endothelial Function of the Micro- and Macrovasculature in Patients With Metabolic Syndrome

TypeinterventionalSponsorUniversity of Erlangen-Nürnberg Medical SchoolRan2010 to 2013Enrolled42ConditionsMetabolic Syndrome, Endothelial DysfunctionArmsEplerenone
NCT06098300 recruitingnot on this mapstarted 2023, after this paper: background citation

Effects of Change in Blood Pressure on Retinal Capillary Rarefaction in Patients With Arterial Hypertension - a Pilot Study

TypeobservationalSponsorMedical University of ViennaRan2023 to 2025Enrolled30ConditionsArterial Hypertension, Blood Pressure, High
3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Trial
  2. Article
  3. Pathophysiology and Clinical Relevance of Microvascular Remodeling in Arterial Hypertension.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Relationship Between Blood Pressure and Heart Rate Response During Exercise Testing with Microcirculation Indices.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2025
    Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Agnes J BoschDepartment of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany.
Joanna M HaraznyDepartment of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany.
Iris KistnerDepartment of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany.
Stefanie FriedrichDepartment of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany.
Joanna WojtkiewiczDepartment of Pathophysiology, University of Warmia and Mazury, Olsztyn, Poland.
Roland E SchmiederDepartment of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany. Roland.Schmieder@uk-erlangen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMicrovascular rarefaction influences peripheral vascular resistance, perfusion and metabolism by affecting blood pressure and flow pattern. In hypertension microvascular rarefaction has been described in experimental animal studies as well as in capillaroscopy of skin and biopsies of muscle tissue in patients. Retinal circulation mirrors cerebral microcirculation and allows non-invasive investigations. We compared capillary rarefaction of retinal vessels in hypertensive versus normotensive subjects.

methodsIn this study retinal capillary rarefaction in 70 patients with long time (more than 67 month of disease duration) and 64 patients with short time hypertension stage 1 or 2 has been compared to 55 healthy control subjects, who participated in clinical trials in our Clinical Research Center ( www.clinicaltrials.gov : NCT01318395, NCT00627952, NCT00152698, NCT01319344). Retinal vascular parameters have been measured non-invasively and in vivo in perfusion image by scanning laser Doppler flowmetry (Heidelberg Engineering, Germany). Capillary rarefaction was assessed by capillary area (CapA) (in pixel-number) and intercapillary distance (ICD) (in μm). Additionally retinal capillary flow (RCF) was measured.

resultsICD was greater in the long time hypertensive group compared to healthy individuals (24.2 ± 6.3 μm vs 20.1 ± 4.2 μm, p = 0.001) and compared to short time hypertensive patients (22.2 ± 5.2 μm, p = 0.020). Long time hypertensive patients showed less CapA compared to healthy people (1462 ± 690 vs 1821 ± 652, p = 0.005). Accordingly, RCF was significantly lower in the long time hypertensive group compared to the healthy control group (282 ± 70 AU vs 314 ± 60 AU, p = 0.032). Our data indicate a lower level of retinal capillary density in hypertensive patients, especially in those with long time hypertension.

conclusionPatients with hypertension stage 1 or 2 showed retinal capillary rarefaction in comparison to healthy normotensive subjects. Retinal capillary rarefaction was intensified with duration of disease.

Indexed as

Blood PressureMicrocirculationMicrovascular RarefactionAdultAgedCapillariesFemaleHumansHypertensionLaser-Doppler FlowmetryMaleMiddle AgedPerfusion ImagingRandomized Controlled Trials as TopicRetinal VesselsRetrospective StudiesCapillary densityCapillary rarefactionHypertensionMicrocirculationRetina

Identifiers

PMID29268712
PMCPMC5740840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.